Viola Mechírová

569 total citations
14 papers, 415 citations indexed

About

Viola Mechírová is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Viola Mechírová has authored 14 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Viola Mechírová's work include Protease and Inhibitor Mechanisms (3 papers), Signaling Pathways in Disease (2 papers) and Mitochondrial Function and Pathology (2 papers). Viola Mechírová is often cited by papers focused on Protease and Inhibitor Mechanisms (3 papers), Signaling Pathways in Disease (2 papers) and Mitochondrial Function and Pathology (2 papers). Viola Mechírová collaborates with scholars based in Slovakia, India and Japan. Viola Mechírová's co-authors include Viola Vargová, Marek Pytliak, Daniel Pella, Ján Fedačko, Kuniaki Otsuka, Adarsh Kumar, Ram B. Singh, Manoj Saxena, Shashank Joshi and Pronobesh Chattopadhyay and has published in prestigious journals such as Biomedicine & Pharmacotherapy, Physiological Research and Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions.

In The Last Decade

Viola Mechírová

12 papers receiving 404 citations

Peers

Viola Mechírová
Viola Mechírová
Citations per year, relative to Viola Mechírová Viola Mechírová (= 1×) peers Viola Vargová

Countries citing papers authored by Viola Mechírová

Since Specialization
Citations

This map shows the geographic impact of Viola Mechírová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viola Mechírová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viola Mechírová more than expected).

Fields of papers citing papers by Viola Mechírová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viola Mechírová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viola Mechírová. The network helps show where Viola Mechírová may publish in the future.

Co-authorship network of co-authors of Viola Mechírová

This figure shows the co-authorship network connecting the top 25 collaborators of Viola Mechírová. A scholar is included among the top collaborators of Viola Mechírová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viola Mechírová. Viola Mechírová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pytliak, Marek, Viola Vargová, & Viola Mechírová. (2012). Matrix Metalloproteinases and Their Role in Oncogenesis: A Review. Onkologie. 35(1-2). 49–53. 54 indexed citations
2.
Vargová, Viola, Marek Pytliak, & Viola Mechírová. (2012). Matrix Metalloproteinases. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 103. 1–33. 47 indexed citations
3.
Pytliak, Marek, et al.. (2011). Serotonin Receptors – From Molecular Biology to Clinical Applications. Physiological Research. 60(1). 15–25. 227 indexed citations
4.
Vargová, Viola, et al.. (2010). Maternal autoimmune thyroiditis and congenital malformations of newborns in a cohort of Slovak women. Wiener Medizinische Wochenschrift. 160(17-18). 470–474. 1 indexed citations
5.
Vargová, Viola, Marek Pytliak, & Viola Mechírová. (2010). Matrix Metalloproteinases and their Tissue Inhibitors in Diabetes, Atherosclerosis and Prediction of the Cardiovascular Risk. Current Enzyme Inhibition. 6(4). 211–224. 1 indexed citations
6.
Fedačko, Ján, et al.. (2009). Abstract: 604 COENZYME Q10 AND SELENIUM SUPPLEMENTATION IN PATIENTS WITH STATIN-ASSOCIATED MYOPATHY. Atherosclerosis Supplements. 10(2). e357–e357. 2 indexed citations
7.
Mechírová, Viola, Ram B. Singh, Ronald R. Watson, et al.. (2008). Can wild whole seeds protect against cardiovascular disease. 1(2). 137–139. 2 indexed citations
9.
Škodová, Zuzana, et al.. (2007). PSYCHOLOGICAL, MEDICAL AND BIO-BEHAVIORAL FACTORS IN CORONARY HEART DISEASE. Studia Psychologica. 49(4). 321–331.
10.
Fedačko, Ján, et al.. (2007). n−3 PUFAs—From dietary supplements to medicines. Pathophysiology. 14(2). 127–132. 11 indexed citations
11.
Kumar, Adarsh, Ram B. Singh, Manoj Saxena, et al.. (2007). Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study.. Acta Cardiologica. 62(4). 349–354. 33 indexed citations
12.
Pella, Daniel, et al.. (2005). Pleiotropic Effects of Statins. Zhōnghuá mínguó xīnzàngxué huì zázhì. 21(4). 190–198. 14 indexed citations
13.
Pella, Daniel, et al.. (2004). Can brain dysfunction be a predisposing factor for metabolic syndrome?. Biomedicine & Pharmacotherapy. 58. S56–S68. 21 indexed citations
14.
Tajtáková, M, et al.. (2003). [The thyroid gland in women during the reproductive age].. PubMed. 68(5). 306–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026